Cardiotrack, a Bengaluru, India-based provider of data-centric healthcare screening technology and services, raised US$2M in Pre-Series A funding.

Cardiotrack是一家总部位于印度班加罗尔的以数据为中心的医疗保健筛查技术和服务提供商，在a系列前期融资中筹集了200万美元。

The round was led by Girish Narasimhan.

这一轮由少女Narasimhan领导。

The company, which had previously received angel investment of US$1.6M from a cohort of UHNIs, intends to use the funds to expand operations and its R&D sector.

该公司之前曾从一群UHNI获得160万美元的天使投资，打算利用这些资金扩大运营和研发部门。

Led by Founder and CEO Avin Agarwal, Cardiotrack delivers at-home pathology and radiology screening services, in 300+ locations through its pan-India network of diagnostic centers, technicians and phlebotomists equipped with its technology, for its customers. The company offers medical and IOT grade diagnostics devices, workflow automation and health data digitisation solutions that empower health & life insurance providers to offer seamless onboarding experiences while enabling their customers to take control of their health.

Cardiotrack由创始人兼首席执行官阿文·阿加瓦尔（Avin Agarwal）领导，通过其由诊断中心、技术人员和静脉切开术专家组成的泛印度网络，在300多个地点为客户提供家庭病理学和放射学筛查服务。该公司提供医疗和物联网级诊断设备、工作流自动化和健康数据数字化解决方案，使健康和人寿保险提供商能够提供无缝的登机体验，同时使客户能够控制自己的健康。

Currently, it serves nine health and life insurance companies, including most of the largest insurers in India.

目前，它为九家健康和人寿保险公司提供服务，其中包括印度大多数最大的保险公司。

Commenting on the news, Avin Agarwal said: “We are thrilled to have secured this investment as we continue to innovate and expand our reach in our mission to drive positive change in the healthcare industry. Our revolutionary approach to healthcare screening not only enhances convenience for consumers but also enables health and life insurance providers to offer fast, comprehensive and personalised services, besides increased operational efficiency and improving our healthcare data analytics capabilities for faster and more accurate insurance underwriting.

评论新闻，阿文·阿加瓦尔说：“我们很高兴能够获得这笔投资，因为我们将继续创新，扩大我们的业务范围，以推动医疗保健行业的积极变革。我们革命性的医疗保健筛查方法不仅为消费者提供了便利，而且还使健康和人寿保险提供商能够提供快速、全面和个性化的服务，此外还增加了运营l提高效率并改进我们的医疗保健数据分析能力，以实现更快、更准确的保险承保。

The investment further validates the venture’s direction and the immense value it brings in improving the healthcare experience for both providers and consumers.” 

这项投资进一步验证了该合资企业的方向及其在改善提供者和消费者的医疗保健体验方面带来的巨大价值。”